BridgeBio Oncology Therapeutics, Inc.
Pharmaceutical Preparations · South San Francisco, CA, United States
- PrincipalsEli M. WallaceChief Executive OfficerPedro BeltranChief Scientific OfficerUneek MehraChief Financial Officerand 2 more
- CompanyBridgeBio Oncology Therapeutics, Inc.South San Francisco, CA, United States
- Phone line+1 (857) 702-0377General business
BridgeBio Oncology Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker BBOT) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 5
Chief executive
Eli M. WallaceChief Executive Officer
Chair & board
Peter F LebowitzDirector (Board)
Finance
Uneek MehraChief Financial Officer
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Pedro Beltran — Chief Scientific Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Uneek Mehra — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Yong Ben — Chief Med & Dev Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Eli M. Wallace — Chief Executive Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Pl. VIIBeOne Medicines Ltd.Pharmaceutical Preparations · Basel1 shared capabilityPl. VIIRoivant Sciences Ltd.Pharmaceutical Preparations · London1 shared capabilityPl. VIIEntera Bio Ltd.Biological Products, (No Diagnostic Substances) · Jerusalem1 shared capabilityPl. VIIDBV Technologies S.A.Biological Products, (No Diagnostic Substances) · Chatillon1 shared capabilityPl. VIIMereo BioPharma Group plcPharmaceutical Preparations · London1 shared capabilityPl. VIIXenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capabilityPl. VIIAdaptimmune Therapeutics PLCBiological Products, (No Diagnostic Substances) · Abingdon, Oxfordshire1 shared capabilityPl. VIIenGene Therapeutics Inc.Biological Products, (No Diagnostic Substances) · Saint-Laurent1 shared capability